VC23

Developer of a multi-omic biomarker measurement tool designed to understand the genetic, environmental, lifestyle and clinical factors that contribute to individual health and wellness. The company provides a quantitative and digital spatial platform that provides nucleic acid and protein assay sensitivity and simultaneous analyte detection while maintaining a simple sample-to-answer workflow, enabling researchers to analyze viral and bacterial targets, mutations, deletions and gene and protein expression more efficiently.

Fluent BioSciences is a privately funded life science company focused on developing high-sensitivity molecular analytical products. Utilizing proprietary instrument-free micro-self-assembly technology, the company enables the analysis of extremely low molecular and cellular sample inputs. Its platform facilitates the instantaneous self-assembly of individual cells or molecules into millions of uniform partitions, allowing for sensitive and unbiased preparation of proteins and nucleic acids for sequencing applications. This innovative approach provides researchers in the biotechnology sector with enhanced capabilities for single-cell analysis, broadening their access to advanced analytical techniques.

Tangen Biosciences LLC develops medical instrument that provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction (PCR) amplification.